These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19137218)

  • 41. New, more reasonable OSHA policy on article and consumer products exceptions to HAZCOM.
    Healthc Hazard Mater Manage; 1995 May; 8(8):7. PubMed ID: 10142907
    [No Abstract]   [Full Text] [Related]  

  • 42. [Genetically modified plants and food safety. State of the art and discussion in the European Union].
    Schauzu M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Sep; 47(9):826-33. PubMed ID: 15378169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrating process safety with molecular modeling-based risk assessment of chemicals within the REACH regulatory framework: benefits and future challenges.
    Lewis A; Kazantzis N; Fishtik I; Wilcox J
    J Hazard Mater; 2007 Apr; 142(3):592-602. PubMed ID: 16930827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generic exposure scenarios: their development, application, and interpretation under REACH.
    Money C; Margary A; Noij D; Hommes K
    Ann Occup Hyg; 2011 Jun; 55(5):451-64. PubMed ID: 21551289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
    Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulatory assessment of chemicals within OECD member countries, EU and in Russia.
    Fjodorova N; Novich M; Vrachko M; Kharchevnikova N; Zholdakova Z; Sinitsyna O; Benfenati E
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(1):40-88. PubMed ID: 18322867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Consumer exposure scenarios: development, challenges and possible solutions.
    Van Engelen JG; Heinemeyer G; Rodriguez C
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S26-33. PubMed ID: 17505503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of reproductive toxicity under REACH.
    Aulmann W
    Regul Toxicol Pharmacol; 2012 Jul; 63(2):286-90. PubMed ID: 22475931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exposure-triggered reproductive toxicity testing under the REACH legislation: a proposal to define significant/relevant exposure.
    Bernauer U; Heinemeyer G; Heinrich-Hirsch B; Ulbrich B; Gundert-Remy U
    Toxicol Lett; 2008 Jan; 176(1):68-76. PubMed ID: 18068317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4)).
    Rovida C; Hartung T
    ALTEX; 2009; 26(3):187-208. PubMed ID: 19907906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
    Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
    Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Scientific basis and regulatory aspects for the toxicology of plant protection products in the European Union.
    Anadón A; Martínez-Larrañaga MR; Martínez MA
    Vet Hum Toxicol; 2001 Oct; 43(5):297-301. PubMed ID: 11577939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transparency of chemical risk assessment data under REACH.
    Ingre-Khans E; Ågerstrand M; Beronius A; Rudén C
    Environ Sci Process Impacts; 2016 Dec; 18(12):1508-1518. PubMed ID: 27819710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Classification of consumer products under the EU CLP Regulation: what to consider when caring for contact dermatitis patients.
    Elsner P
    Contact Dermatitis; 2018 Jan; 78(1):1-6. PubMed ID: 29148058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. European activities in radiation protection in medicine.
    Simeonov G
    Radiat Prot Dosimetry; 2015 Jul; 165(1-4):34-8. PubMed ID: 25870434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proper knowledge on toxicokinetics improves human hazard testing and subsequent health risk characterisation. A case study approach.
    Bessems JG; Geraets L
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):325-34. PubMed ID: 24051162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Food-borne zoonoses, the EU zoonosis legislation and the prospects for food safety and consumer protection during primary animal production.
    Smulders FJ; Vågsholm I; Korkeala H
    Wien Klin Wochenschr; 2008; 120(19-20):587-98. PubMed ID: 19083162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of REACH on classification for human health hazards.
    Oltmanns J; Bunke D; Jenseit W; Heidorn C
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):474-81. PubMed ID: 25128672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the California Safer Consumer Products Regulation and the impact on consumers and product manufacturers.
    Cowan DM; Kingsbury T; Perez AL; Woods TA; Kovochich M; Hill DS; Madl AK; Paustenbach DJ
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):23-40. PubMed ID: 24231524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.